SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-072899
Filing Date
2020-06-12
Accepted
2020-06-12 16:06:26
Documents
64
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2021863d1_10q.htm 10-Q 380786
2 EXHIBIT 31.1 tm2021863d1_ex31-1.htm EX-31.1 11078
3 EXHIBIT 31.2 tm2021863d1_ex31-2.htm EX-31.2 11030
4 EXHIBIT 32.1 tm2021863d1_ex32-1.htm EX-32.1 4878
5 EXHIBIT 32.2 tm2021863d1_ex32-2.htm EX-32.2 5070
  Complete submission text file 0001104659-20-072899.txt   4387430

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tmbr-20200430.xml EX-101.INS 986726
7 XBRL TAXONOMY EXTENSION SCHEMA tmbr-20200430.xsd EX-101.SCH 48731
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmbr-20200430_cal.xml EX-101.CAL 37178
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmbr-20200430_def.xml EX-101.DEF 196590
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmbr-20200430_lab.xml EX-101.LAB 407263
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmbr-20200430_pre.xml EX-101.PRE 339875
Mailing Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677 973-314-9570
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 20960267
SIC: 2834 Pharmaceutical Preparations